Johnson W, Mishra A, Binder A, Gru A, Porcu P. Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?. Haematologica [Internet]. 2019Apr.30 [cited 2026Nov.8];104(5):864-7. Available from: https://haematologica.org/article/view/8888